Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | CPA1 | P15085 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2295176 | 0.98 | PSMB5 (0.47) | PSMB5MAPTALDH1A1RECQLCTNNB1 | |
| Hydrochloric Acid SCHEMBL2297582 | 0.96 | PSMB5 (0.47) | PSMB5MAPTALDH1A1RECQLCTNNB1 | |
| Levacetylleucine SCHEMBL6674776 | 0.88 | PSMB5 (0.48) | PSMB5ALDH1A1MMP2MMP9MMP8 | |
| Leucine SCHEMBL27471555 | 0.88 | MAPT (0.47) | PSMB5MAPTALDH1A1RECQLCTNNB1 | |
| Leucine SCHEMBL27470583 | 0.86 | MAPT (0.50) | MAPTALDH1A1RECQLCTNNB1MME | |
| Leucine SCHEMBL6672109 | 0.86 | MAPT (0.50) | MAPTALDH1A1RECQLCTNNB1MME | |
| SCHEMBL29397866 | 0.82 | CTNNB1 (0.59) | MAPTALDH1A1RECQLCTNNB1SLC1A3 | |
| SCHEMBL93516 | 0.82 | CTNNB1 (0.59) | MAPTALDH1A1RECQLCTNNB1SLC1A3 | |
| SCHEMBL660499 | 0.82 | CTNNB1 (0.59) | MAPTALDH1A1RECQLCTNNB1SLC1A3 | |
| SCHEMBL29482763 | 0.82 | CTNNB1 (0.59) | MAPTALDH1A1RECQLCTNNB1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2904115-A2 | BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2776043-A1 | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS | Millennium Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776586-A2 | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS | Millennium Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| WO-2014055543-A2 | BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2014-04-10 | — | — | WO | disclosed |
| EP-2606349-A1 | CANCER DIAGNOSTIC AND CANCER THERAPEUTIC | Pangea Biosciences Inc. (US) | 2013-06-26 | — | — | EP | disclosed |
| WO-2013071163-A2 | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS | MILLENNIUM PHARAMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013071142-A1 | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2012024612-A1 | CANCER DIAGNOSTIC AND CANCER THERAPEUTIC | PANGEA BIOSCIENCES, INC. (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2009148528-A2 | ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-12-10 | — | — | WO | disclosed |